Skip to main content
Log in

Refractory sprue

  • Published:
Current Gastroenterology Reports Aims and scope Submit manuscript

Abstract

Celiac disease is a T cell-mediated disorder that results from intolerance to gluten. The major cause of failure to respond to a gluten-free diet is continuing gluten ingestion. In poorly responsive patients diagnosis of refractory sprue can be established after exclusion of a limited number of conditions. Refractory sprue may occur after an initial response to the diet or without evidence of preexisting celiac disease. The detection of aberrant, clonally expanded, intraepithelial lymphocytes has led to better definition and classification of patients with refractory sprue. Only a few series of patients with well-characterized refractory sprue have been reported in the literature. The prognosis is poor, though some patients respond to corticosteroids and immunosuppressive agents. The presence of an aberrant clonal intraepithelial T-cell population has led to the designation of refractory sprue as a cryptic intestinal T-cell lymphoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References and Recommended Reading

  1. Ciclitira PJ, King AL, Fraser JS: AGA technical review on celiac Sprue. American Gastroenterological Association. Gastroenterology 2001, 120:1526–1540.

    PubMed  CAS  Google Scholar 

  2. Lo W, Sano K, Lebwohl B, et al.: Changing presentation of adult celiac disease. Dig Dis Sci 2003, 48:395–398.

    Article  PubMed  Google Scholar 

  3. Marsh MN: Gluten, major histocompatibility complex, and the small intestine: a molecular and immunobiologic approach to the spectrum of gluten sensitivity (‘celiac sprue’). Gastroenterology 1992, 102:330–354. An important article classifying the pathologic findings in celiac disease.

    PubMed  CAS  Google Scholar 

  4. Walker-Smith JA, Schmerling DM, Visakorpi JK: Revised criteria for diagnosis of coeliac disease: report of Working Group of European Society of Paediatric Gastroenterology and Nutrition. Arch Dis Child 1990, 65:909–911.

    Article  Google Scholar 

  5. Ryan BM, Kelleher D: Refractory celiac disease. Gastroenterology 2000, 119:243–251.

    Article  PubMed  CAS  Google Scholar 

  6. Abdulkarim AS, Burgart LJ, See J, Murray JA: Etiology of nonresponsive celiac disease: results of a systematic approach. Am J Gastroenterol 2002, 97:2016–2021. A good example of the range of causes for poorly responsive celiac disease.

    Article  PubMed  Google Scholar 

  7. Shidrawi RG, Przemioslo R, Davies DR, et al.: Pitfalls in diagnosing coeliac disease. J Clin Pathol 1994, 47:693–694.

    PubMed  CAS  Google Scholar 

  8. Lee SK, Lo W, Memeo L, et al.: Duodenal histology in patients with celiac disease after treatment with a gluten-free diet. Gastrointest Endosc 2003, 57:187–191.

    Article  PubMed  Google Scholar 

  9. Wahab PJ, Meijer JW, Mulder CJ: Histologic follow-up of people with celiac disease on a gluten-free diet: slow and incomplete recovery. Am J Clin Pathol 2002, 118:459–463.

    Article  PubMed  Google Scholar 

  10. Sategna-Guidetti C, Pulitano R, Grosso S, Ferfoglia G: Serum IgA antiendomysium antibody titers as a marker of intestinal involvement and diet compliance in adult celiac sprue. J Clin Gastroenterol 1993, 17:123–127.

    Article  PubMed  CAS  Google Scholar 

  11. Dickey W, Hughes DF, McMillan SA: Disappearance of endomysial antibodies in treated celiac disease does not indicate histological recovery. Am J Gastroenterol 2000, 95:712–714.

    Article  PubMed  CAS  Google Scholar 

  12. Troncone R, Mayer M, Spagnuolo F, et al.: Endomysial antibodies as unreliable markers for slight dietary transgressions in adolescents with celiac disease. J Pediatr Gastroenterol Nutr 1995, 21:69–72.

    Article  PubMed  CAS  Google Scholar 

  13. Fine KD, Meyer RL, Lee EL: The prevalence and causes of chronic diarrhea in patients with celiac sprue treated with a gluten-free diet. Gastroenterology 1997, 112:1830–1838.

    Article  PubMed  CAS  Google Scholar 

  14. Carroccio A, Iacono G, Montalto G, et al.: Pancreatic enzyme therapy in childhood celiac disease: a double-blind prospective randomized study. Dig Dis Sci 1995, 40:2555–2260.

    Article  PubMed  CAS  Google Scholar 

  15. Tursi A, Brandimarte G, Giorgetti G: High prevalence of small intestinal bacterial overgrowth in celiac patients with persistence of gastrointestinal symptoms after gluten withdrawal. Am J Gastroenterol 2003, 98:839–843.

    Article  PubMed  Google Scholar 

  16. Corazza GR, Biagi F, Volta U, et al.: Autoimmune enteropathy and villous atrophy in adults. Lancet 1997, 350:106–109.

    Article  PubMed  CAS  Google Scholar 

  17. Trier JS, Falchuk ZM, Carey MC, Schreiber DS: Celiac sprue and refractory sprue. Gastroenterology 1978, 75:307–316.

    PubMed  CAS  Google Scholar 

  18. Biagi F, Corazza GR: Defining gluten refractory enteropathy. Eur J Gastroenterol Hepatol 2001, 13:561–565.

    Article  PubMed  CAS  Google Scholar 

  19. Cellier C, Delabesse E, Helmer C, et al.: Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French Coeliac Disease Study Group. Lancet 2000, 356:203–208. A landmark paper describing the role of determining T-cell clonality in refractory patients.

    Article  PubMed  CAS  Google Scholar 

  20. Maurino E, Niveloni S, Chernavsky A, et al.: Azathioprine in refractory sprue: results from a prospective, open-label study. Am J Gastroenterol 2002, 97:2595–2602. A good paper describing therapy for refractory sprue.

    PubMed  CAS  Google Scholar 

  21. Robert ME, Ament ME, Weinstein WM: The histologic spectrum and clinical outcome of refractory and unclassified sprue. Am J Surg Pathol 2000, 24:676–687.

    Article  PubMed  CAS  Google Scholar 

  22. Bardella MT, Trovato C, Quatrini M, Conte D: Mesenteric lymph node cavitation: a rare hallmark of celiac disease. Scand J Gastroenterol 1999, 34:1257–1259.

    Article  PubMed  CAS  Google Scholar 

  23. Sollid LM: Coeliac disease: dissecting a complex inflammatory disorder. Nat Rev Immunol 2002, 2:647–655. An up-to-date review of the immunopathology of celiac disease.

    Article  PubMed  CAS  Google Scholar 

  24. Daum S, Weiss D, Hummel M, et al.: Frequency of clonal intraepithelial T lymphocyte proliferations in enteropathytype intestinal T cell lymphoma, coeliac disease, and refractory sprue. Gut 2001, 49:804–812.

    Article  PubMed  CAS  Google Scholar 

  25. Cellier C, Patey N, Mauvieux L, et al.: Abnormal intestinal intraepithelial lymphocytes in refractory sprue. Gastroenterology 1998, 114:471–481.

    Article  PubMed  CAS  Google Scholar 

  26. Patey-Mariaud De Serre N, Cellier C, Jabri B, et al.: Distinction between coeliac disease and refractory sprue: a simple immunohistochemical method. Histopathology 2000, 37:70–77.

    Article  Google Scholar 

  27. Jabri B, Cellier C, Patey N, et al.: Intraepithelial lymphocytes in Coeliac disease. In Proceedings of the Eighth International Symposium on Coeliac Disease. Edited by Auricchio S, Greco L, Maiuri L. Naples, Italy: CNR, Instituto di Science dell’Alimentazione Avellina; 2000.

    Google Scholar 

  28. Verkarre V, Asnafi V, Lecomte T, et al.: Refractory coeliac sprue is a diffuse gastrointestinal disease. Gut 2003, 52:205–211.

    Article  PubMed  CAS  Google Scholar 

  29. Cellier C, Cuillerier E, Patey-Mariaud de Serre N, et al.: Push enteroscopy in celiac sprue and refractory sprue. Gastrointest Endosc 1999, 50:613–617.

    Article  PubMed  CAS  Google Scholar 

  30. Carbonnel F, Grollet-Bioul L, Brouet JC, et al.: Are complicated forms of celiac disease cryptic T-cell lymphomas? Blood 1998, 92:3879–3886.

    PubMed  CAS  Google Scholar 

  31. Green PH, Jabri B: Celiac disease and other precursors to small-bowel malignancy. Gastroenterol Clin North Am 2002, 31:625–639.

    Article  PubMed  Google Scholar 

  32. Weinstein WM, Saunders DR, Tytgat GN, Rubin CE: Collagenous sprue: an unrecognized type of malabsorption. N Engl J Med 1970, 283:1297–12301.

    Article  PubMed  CAS  Google Scholar 

  33. Bossart R, Henry K, Doe WF, Booth CC: Collagenous basement membrane thickening in jejunal biopsies from patients with adult coeliac disease. Gut 1974, 15:338.

    PubMed  CAS  Google Scholar 

  34. Bayless TM, Kapelowitz RF, Shelley WM, et al.: Intestinal ulceration: a complication of celiac disease. N Engl J Med 1967, 276:996–1002.

    Article  PubMed  CAS  Google Scholar 

  35. Baer AN, Bayless TM, Yardley JH: Intestinal ulceration and malabsorption syndromes. Gastroenterology 1980, 79:754–765.

    PubMed  CAS  Google Scholar 

  36. Ashton-Key M, Diss TC, Pan L, et al.: Molecular analysis of Tcell clonality in ulcerative jejunitis and enteropathy-associated T-cell lymphoma. Am J Pathol 1997, 151:493–498.

    PubMed  CAS  Google Scholar 

  37. Longstreth GF: Successful treatment of refractory sprue with cyclosporine. Ann Intern Med 1993, 119:1014–1016.

    PubMed  CAS  Google Scholar 

  38. Rolny P, Sigurjonsdottir HA, Remotti H, et al.: Role of immunosuppressive therapy in refractory sprue-like disease. Am J Gastroenterol 1999, 94:219–225.

    Article  PubMed  CAS  Google Scholar 

  39. Wahab PJ, Crusius JB, Meijer JW, et al.: Cyclosporin in the treatment of adults with refractory coeliac disease: an open pilot study. Aliment Pharmacol Ther 2000, 14:767–774.

    Article  PubMed  CAS  Google Scholar 

  40. Hamilton JD, Chambers RA, Wynn-Williams A: Role of gluten, prednisone, and azathioprine in non-responsive coeliac disease. Lancet 1976, 1:1213–1216.

    Article  PubMed  CAS  Google Scholar 

  41. Vaidya A, Bolanos J, Berkelhammer C: Azathioprine in refractory sprue. Am J Gastroenterol 1999, 94:1967–1969.

    Article  PubMed  CAS  Google Scholar 

  42. Gillett HR, Arnott ID, McIntyre M, et al.: Successful infliximab treatment for steroid-refractory celiac disease: a case report. Gastroenterology 2002, 122:800–805.

    Article  PubMed  Google Scholar 

  43. Mulder CJ, Wahab PJ, Meijer JW, Metselaar E: A pilot study of recombinant human interleukin-10 in adults with refractory coeliac disease. Eur J Gastroenterol Hepatol 2001, 13:1183–1188.

    Article  PubMed  CAS  Google Scholar 

  44. Goerres MS, Wahab P, Kerchhaert J, et al.: Cladribine treatment in refractory coeliac disease type II [abstract]. Gastroenterology 2003, 124(Suppl 1):131.

    Google Scholar 

  45. Walker-Smith JA: Cow milk-sensitive enteropathy: predisposing factors and treatment. J Pediatr 1992, 121(5 Pt 2): S111–5.

    Article  PubMed  CAS  Google Scholar 

  46. Ament ME, Rubin CE: Soy protein: another cause of the flat intestinal lesion. Gastroenterology 1972, 62:227–234.

    PubMed  CAS  Google Scholar 

  47. Baker AL, Rosenberg IH: Refractory sprue: recovery after removal of nongluten dietary proteins. Ann Intern Med 1978, 89:505–508.

    PubMed  CAS  Google Scholar 

  48. Mandal A, Mayberry J: Elemental diet in the treatment of refractory coeliac disease. Eur J Gastroenterol Hepatol 2001, 13:79–80.

    Article  PubMed  CAS  Google Scholar 

  49. Roberts AI, Lee L, Schwarz E, et al.: NKG2D receptors induced by IL-15 costimulate CD28-negative effector CTL in the tissue microenvironment. J Immunol 2001, 167:5527–5530.

    PubMed  CAS  Google Scholar 

  50. Fehniger TA, Suzuki K, VanDeusen JB, et al.: Fatal leukemia in interleukin-15 transgenic mice. Blood Cells Mol Dis 2001, 27:223–230.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Culliford, A.N., Green, P.H.R. Refractory sprue. Curr Gastroenterol Rep 5, 373–378 (2003). https://doi.org/10.1007/s11894-003-0049-z

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11894-003-0049-z

Keywords

Navigation